Employers, lawmakers and more said regulators should hustle to get disclosure mandates for the controversial drug middlemen across the finish line, while PBMs slammed the rule as illegal, unnecessary and anticompetitive.
Healthcare Dive published a clinical update in Research Highlights on 17 Apr 2026. The item focuses on Stakeholders urge Labor Department to finalize PBM transparency rule. Open the detail page to review the full original feed content.